Bronchoscopic Journey of in vivo Real-Time Microscopic Imaging in ILD: A Case Series.
Bronchoscopy
Confocal laser endomicroscopy
Histology
Interstitial lung disease
Optical coherence tomography
Journal
Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
11
2021
accepted:
20
06
2022
pubmed:
1
9
2022
medline:
29
11
2022
entrez:
31
8
2022
Statut:
ppublish
Résumé
Patients with interstitial lung diseases (ILDs) frequently present with nondiagnostic high-resolution CT (HRCT) scan and bronchoalveolar lavage (BAL) results, resulting in the need for invasive surgical or cryo-lung biopsy that is associated with significant morbidity. Confocal laser endomicroscopy (CLE) and optical coherence tomography (OCT) are high-resolution laser and light-based techniques that provide real-time imaging of the alveolar compartment during bronchoscopy with a different depth and field of view. The aim of the study was to correlate OCT and CLE imaging to HRCT imaging in ILD. This is a retrospective case series of 20 ILD patients who underwent alveolar CLE and OCT imaging during a standard bronchoscopy with BAL, followed by a lung biopsy when indicated. CLE and OCT imaging were compared to four main HRCT patterns and histology. The final diagnosis was based on the multidisciplinary discussion diagnosis. Bronchoscopic CLE and OCT imaging were feasible and safe and provided additional high-detailed anatomical information compared to the HRCT. Bronchoscopic real-time CLE was capable of identification of "alveolar cells" (ground glass opacities) and lung fibrosis (increased alveolar elastin fibers). Bronchoscopic real-time OCT allowed for visualization of "patchy fibrotic disease", "honeycombing" (microcysts), and mucosal granulomas in the airways. Bronchoscopic CLE and OCT of the alveolar compartment is feasible and safe and enables minimally invasive, high-resolution detection of specific ILD features with the potential to improve ILD diagnostics and monitoring and decrease the need for surgical or cryo-lung biopsies.
Sections du résumé
BACKGROUND
Patients with interstitial lung diseases (ILDs) frequently present with nondiagnostic high-resolution CT (HRCT) scan and bronchoalveolar lavage (BAL) results, resulting in the need for invasive surgical or cryo-lung biopsy that is associated with significant morbidity. Confocal laser endomicroscopy (CLE) and optical coherence tomography (OCT) are high-resolution laser and light-based techniques that provide real-time imaging of the alveolar compartment during bronchoscopy with a different depth and field of view.
OBJECTIVES
The aim of the study was to correlate OCT and CLE imaging to HRCT imaging in ILD.
METHODS
This is a retrospective case series of 20 ILD patients who underwent alveolar CLE and OCT imaging during a standard bronchoscopy with BAL, followed by a lung biopsy when indicated. CLE and OCT imaging were compared to four main HRCT patterns and histology. The final diagnosis was based on the multidisciplinary discussion diagnosis.
RESULTS
Bronchoscopic CLE and OCT imaging were feasible and safe and provided additional high-detailed anatomical information compared to the HRCT. Bronchoscopic real-time CLE was capable of identification of "alveolar cells" (ground glass opacities) and lung fibrosis (increased alveolar elastin fibers). Bronchoscopic real-time OCT allowed for visualization of "patchy fibrotic disease", "honeycombing" (microcysts), and mucosal granulomas in the airways.
CONCLUSIONS
Bronchoscopic CLE and OCT of the alveolar compartment is feasible and safe and enables minimally invasive, high-resolution detection of specific ILD features with the potential to improve ILD diagnostics and monitoring and decrease the need for surgical or cryo-lung biopsies.
Identifiants
pubmed: 36044868
pii: 000526045
doi: 10.1159/000526045
pmc: PMC9811420
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1006-1014Informations de copyright
© 2022 The Author(s). Published by S. Karger AG, Basel.
Références
Rev Port Pneumol (2006). 2017 Nov - Dec;23(6):331-337
pubmed: 28800873
Curr Opin Pulm Med. 2017 May;23(3):275-283
pubmed: 28212154
Respiration. 2018;95(3):188-200
pubmed: 29316560
QJM. 2017 Apr 01;110(4):207-214
pubmed: 27521581
Endosc Ultrasound. 2012 Jul;1(2):80-3
pubmed: 24949342
Respiration. 2015;90(4):275-8
pubmed: 26384323
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Endoscopy. 2016 Oct;48(10):892-8
pubmed: 27576181
PLoS One. 2017 Oct 5;12(10):e0184145
pubmed: 28981500
Respiration. 2016;91(3):215-27
pubmed: 26926876
Eur Respir J. 2009 May;33(5):974-85
pubmed: 19213792
Am J Respir Crit Care Med. 2013 Jul 15;188(2):141-9
pubmed: 23672718
Respiration. 2020;99(3):190-205
pubmed: 31593955
J Appl Physiol (1985). 2012 Sep;113(6):967-74
pubmed: 22773771
Science. 1997 Jun 27;276(5321):2037-9
pubmed: 9197265
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75
pubmed: 27299520
Respiration. 2009;78(2):203-8
pubmed: 19246874
Monaldi Arch Chest Dis. 2019 Sep 10;89(3):
pubmed: 31505921
Br J Ophthalmol. 2017 Jan;101(1):16-20
pubmed: 27707691
Science. 1991 Nov 22;254(5035):1178-81
pubmed: 1957169
Am J Respir Crit Care Med. 2018 Apr 1;197(7):949-952
pubmed: 28934552
Respiration. 2019;97(3):259-263
pubmed: 30428462
Lancet Respir Med. 2018 Feb;6(2):138-153
pubmed: 29154106
Am J Respir Crit Care Med. 2021 Nov 15;204(10):1164-1179
pubmed: 34375171
Eur Respir J. 2013 Dec;42(6):1646-58
pubmed: 23018901
J Clin Pathol. 2009 May;62(5):387-401
pubmed: 19398592